“Phase IV Evaluation of the Adrenal Suppression Potential and PKPD of Halobetasol Propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis” (2021) SKIN The Journal of Cutaneous Medicine, 5(6), p. s47. doi:10.25251/skin.5.supp.47.